Limbach Holdings (LMB) Tops Q3 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance

Go back to Limbach Holdings (LMB) Tops Q3 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance
Holmes Biopharma, Inc. (NASDAQ: LMB) Delayed: 80.15 -0.19 (0.24%)
Previous Close $80.34    52 Week High $0.15 
Open $81.39    52 Week Low $0.15 
Day High $83.00    P/E N/A 
Day Low $79.13    EPS $0.00 
Volume 260,971